Takeda, Mylan Drop Claims In Diabetes Drug Suit

By Ryan Davis · October 22, 2008, 12:00 AM EDT

Takeda Pharmaceutical Co. Ltd. and Mylan Inc. have agreed to dismiss claims related to one of four patents at issue in a lawsuit over Mylan's plans to develop a generic version...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Complaint

Recent Articles By Ryan

January 02, 2025
Issa Again Selected To Lead House IP Subcommittee
December 16, 2024
The Biggest Patent Decisions Of 2024
November 21, 2024
In Tight Vote, Senate Panel OKs Bill To Set New PTAB Limits
October 28, 2024
Judge Leaves Patent Case After Fed. Circ. Undoes Ruling
October 18, 2024
What Attorneys Expect From Harris And Trump On Patents
October 07, 2024
High Court Rejects Pleas To Hear 7 Patent Cases
September 26, 2024
Senate Patent Bill Markups Delayed Until After Election
September 18, 2024
Fed. Circ. Revives Astellas Patent Axed As Natural Law
August 20, 2024
Vax Patent Battles Heat Up As Attention On Pandemic Wanes
June 21, 2024
Drugmakers Decline To Drop Patent Listings After FTC Letters